1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Facial Injectables Market, by Type
6.1. Introduction
6.2. Anti-aging Injections
6.2.1. Botulinum Toxin A
6.2.2. Poly-L-Lactic Acid (PLLA) Micro Particles
6.3. Dermal Fillers
6.3.1. Collagen Fillers
6.3.2. Hyaluronic Acid
6.3.3. Synthetic Fillers

7. Facial Injectables Market, by End User
7.1. Introduction
7.2. Beauty Clinics
7.3. Dermatology Clinics
7.4. Dermatology Research Institutes
7.5. Hospitals

8. California Facial Injectables Market

9. Florida Facial Injectables Market

10. Illinois Facial Injectables Market

11. New York Facial Injectables Market

12. Ohio Facial Injectables Market

13. Pennsylvania Facial Injectables Market

14. Texas Facial Injectables Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Advanced Dermatology
16.2. Allergan, Plc
16.3. Anika Therapeutics, Inc.
16.4. Antares Pharma
16.5. AstraZeneca
16.6. Becton, Dickinson and Company
16.7. Bloomage BioTechnology Corporation Limited
16.8. ColBar LifeScience Ltd.
16.9. Eisai Co. Ltd
16.10. Eli Lilly and Company,
16.11. F. Hoffmann-La Roche AG,
16.12. Galderma Laboratories, L.P.
16.13. Inovio Pharmaceuticals Inc.
16.14. Ipse
16.15. Johnson and Johnson Services Inc.
16.16. Medytox, Inc.
16.17. Merz, Inc.
16.18. Mylan N. V.
16.19. Novartis AG
16.20. Novo Nordisk
16.21. Pfizer Inc
16.22. Prollenium Medical Technologies Inc.
16.23. Sanofi
16.24. Sanofi Biosurgery Inc.
16.25. Sinclair Pharma
16.26. Suneva Medical, Inc.
16.27. Teva Pharmaceutical Industries Ltd
16.28. Valeant Pharmaceuticals North America LLC.

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES FACIAL INJECTABLES MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES FACIAL INJECTABLES MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2027
FIGURE 6. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, 2018-2027 (USD MILLION)
FIGURE 17. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 21. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2027
FIGURE 23. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 30. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES FACIAL INJECTABLES MARKET: FPNV POSITIONING MATRIX
FIGURE 32. UNITED STATES FACIAL INJECTABLES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 33. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES FACIAL INJECTABLES MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES FACIAL INJECTABLES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES FACIAL INJECTABLES MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES FACIAL INJECTABLES MARKET: SCORES
TABLE 17. UNITED STATES FACIAL INJECTABLES MARKET: BUSINESS STRATEGY
TABLE 18. UNITED STATES FACIAL INJECTABLES MARKET: PRODUCT SATISFACTION
TABLE 19. UNITED STATES FACIAL INJECTABLES MARKET: RANKING
TABLE 20. UNITED STATES FACIAL INJECTABLES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 21. UNITED STATES FACIAL INJECTABLES MARKET: MERGER & ACQUISITION
TABLE 22. UNITED STATES FACIAL INJECTABLES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 23. UNITED STATES FACIAL INJECTABLES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 24. UNITED STATES FACIAL INJECTABLES MARKET: INVESTMENT & FUNDING
TABLE 25. UNITED STATES FACIAL INJECTABLES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 26. UNITED STATES FACIAL INJECTABLES MARKET: LICENSE & PRICING

Companies Mentioned

Advanced Dermatology
Allergan, Plc
Anika Therapeutics, Inc.
Antares Pharma
AstraZeneca
Becton, Dickinson and Company
Bloomage BioTechnology Corporation Limited
ColBar LifeScience Ltd.
Eisai Co. Ltd
Eli Lilly and Company,
F. Hoffmann-La Roche AG,
Galderma Laboratories, L.P.
Inovio Pharmaceuticals Inc.
Ipse
Johnson and Johnson Services Inc.
Medytox, Inc.
Merz, Inc.
Mylan N. V.
Novartis AG
Novo Nordisk
Pfizer Inc
Prollenium Medical Technologies Inc.
Sanofi
Sanofi Biosurgery Inc.
Sinclair Pharma
Suneva Medical, Inc.
Teva Pharmaceutical Industries Ltd
Valeant Pharmaceuticals North America LLC.